/

Investors / United States / BioAdvance

BioAdvance

Venture capital · Conshohocken, PA, United States · North America

bioadvance.comTakes pitches from founders

BioAdvance is an evergreen fund that provides early-stage funding to life-science companies. It invests in companies headquartered in the Mid-Atlantic region along the I-95 corridor between New York City and Washington, D.C., and works closely with entrepreneurs to help them reach milestones and attract follow-on funding.

Invests inHealthcare & Biotech

In its own wordslife sciencestherapeuticsmedical devicesdigital healthdiagnosticsresearch tools

Your fit with BioAdvance

Four questions about your startup

See how your round matches what it backs, point by point.

Or find every investor that fits
6portfolio companies
0funding rounds on record
Seed to Series Astages it states

BioAdvance lists 6 checked portfolio companies on its own site. Its largest theme is Healthcare & Biotech (100%). 100% of its companies are based in United States. It invests most often alongside Agent Capital, Hatch Biofund and ADIT Ventures.

No funding round on record names BioAdvance yet, so the figures come from its portfolio page.

Investor profile

percentile among all firms
Portfolio size: 6 companiesRecent activity: 0 rounds in 12 monthsEarly stage: 0% of entries at pre-seed or seedEvidence: 0% of companies confirmed by a roundSector focus: 100% in its largest sectorReach: 1 countryPortfolio size8th pctRecent activity46th pctEarly stage54th pctEvidence52th pctSector focus100th pctReach19th pct
This firmMedian of all firms
Show as a table
BioAdvance compared with all firms
MeasurePercentile of all firmsValue
Portfolio size8th6 companies
Recent activity46th0 rounds in 12 months
Early stage54th0% of entries at pre-seed or seed
Evidence52th0% of companies confirmed by a round
Sector focus100th100% in its largest sector
Reach19th1 country

Its portfolio companies

where they are based, and what their own sites show

Headquarters

Site status

  • Site answers6100%
  • No longer answers00%
  • Points to another company00%
  • Parked or sold domain00%

A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.

Investment themes

share of its checked companies

This firmAll checked companies

Show as a table
Investment themes
This firmAll checked companies
Healthcare & Biotech100%15%

Compare BioAdvance head to head

portfolio size, rounds, entry stages, themes and the companies both back

Three or more firms at once: portfolio overlap.

Portfolio

6 companies checked against their own sites
CompanyWhat it doesThemesFirst round with itEvidence
ImmunoGenesisimmunogenesis.comImmunoGenesis is engineering next-generation immunotherapies designed for hardest-to-treat tumors.
Healthcare & Biotech
Portfolio page
Latus Biolatusbio.com · United StatesThe company develops gene therapies designed to target the right cell types in the right tissues, to fundamentally impact genetic diseases
Healthcare & Biotech
Portfolio page
Palvella Therapeuticspalvellatx.comPalvella Therapeutics exists to address rare skin diseases with no approved therapies by developing targeted topical treatments
Healthcare & Biotech
Portfolio page
Strados Labsstradoslabs.com · United StatesStrados Labs provides respiratory endpoint solutions for clinical trials
Healthcare & Biotech
Portfolio page
Tolerance Biotolerancebio.com · United StatesTolerance Bio increases health span by preserving, restoring, and modulating the function of the thymus, the master regulator of immune tolerance
Healthcare & Biotech
Portfolio page
Vittoria Biotherapeuticsvittoriabio.com · United StatesVittoria Biotherapeutics is a clinical-stage company that develops immunotherapies to address unmet clinical needs in oncology and immunology
Healthcare & Biotech
Portfolio page

About this data

site last read 13 Nov 2026
The homepage of BioAdvance, as last read
bioadvance.com as VCinfo last read it
Site
bioadvance.com
Last read
13 Nov 2026
Watching since
7 Nov 2026
Companies checked
6

Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.

How we grade the data

Free account · no card

Get BioAdvance's profile as data

Pull BioAdvance's portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.

Work email, sign-in link by email. Already have an account? Log in
  • Ask AI5 plain-English investor searches a day
  • Full listsEvery portfolio row and two-firm overlap
  • API and MCP100 REST or MCP calls a month, one key
  • AlertsFollow 5 investors for portfolio and fund changes
VCinfo API
$ curl -H "X-API-Key: YOUR_KEY" \
  https://api.vcinfo.io/v1/firms/bioadvance.com

# also
GET /v1/firms/bioadvance.com/portfolio
GET /v1/firms/bioadvance.com/coinvestors
GET /v1/firms/bioadvance.com/news
The same data as an MCP server for Claude, Cursor and other AI tools. Set up MCP · Docs · Pricing